S&P 500   3,901.30 (+2.37%)
DOW   31,587.41 (+2.12%)
QQQ   321.96 (+2.49%)
AAPL   126.23 (+4.10%)
MSFT   236.55 (+1.79%)
FB   262.03 (+1.71%)
GOOGL   2,057.66 (+1.77%)
TSLA   709.64 (+5.05%)
AMZN   3,126.00 (+1.07%)
NVDA   546.34 (-0.41%)
BABA   240.66 (+1.22%)
CGC   34.79 (+6.23%)
GE   13.19 (+5.18%)
MU   93.96 (+2.65%)
NIO   49.69 (+8.54%)
AMD   85.75 (+1.47%)
T   28.19 (+1.08%)
F   11.98 (+2.39%)
ACB   11.21 (+6.56%)
DIS   194.37 (+2.82%)
BA   223.06 (+5.21%)
NFLX   548.12 (+1.72%)
BAC   35.87 (+3.34%)
S&P 500   3,901.30 (+2.37%)
DOW   31,587.41 (+2.12%)
QQQ   321.96 (+2.49%)
AAPL   126.23 (+4.10%)
MSFT   236.55 (+1.79%)
FB   262.03 (+1.71%)
GOOGL   2,057.66 (+1.77%)
TSLA   709.64 (+5.05%)
AMZN   3,126.00 (+1.07%)
NVDA   546.34 (-0.41%)
BABA   240.66 (+1.22%)
CGC   34.79 (+6.23%)
GE   13.19 (+5.18%)
MU   93.96 (+2.65%)
NIO   49.69 (+8.54%)
AMD   85.75 (+1.47%)
T   28.19 (+1.08%)
F   11.98 (+2.39%)
ACB   11.21 (+6.56%)
DIS   194.37 (+2.82%)
BA   223.06 (+5.21%)
NFLX   548.12 (+1.72%)
BAC   35.87 (+3.34%)
S&P 500   3,901.30 (+2.37%)
DOW   31,587.41 (+2.12%)
QQQ   321.96 (+2.49%)
AAPL   126.23 (+4.10%)
MSFT   236.55 (+1.79%)
FB   262.03 (+1.71%)
GOOGL   2,057.66 (+1.77%)
TSLA   709.64 (+5.05%)
AMZN   3,126.00 (+1.07%)
NVDA   546.34 (-0.41%)
BABA   240.66 (+1.22%)
CGC   34.79 (+6.23%)
GE   13.19 (+5.18%)
MU   93.96 (+2.65%)
NIO   49.69 (+8.54%)
AMD   85.75 (+1.47%)
T   28.19 (+1.08%)
F   11.98 (+2.39%)
ACB   11.21 (+6.56%)
DIS   194.37 (+2.82%)
BA   223.06 (+5.21%)
NFLX   548.12 (+1.72%)
BAC   35.87 (+3.34%)
S&P 500   3,901.30 (+2.37%)
DOW   31,587.41 (+2.12%)
QQQ   321.96 (+2.49%)
AAPL   126.23 (+4.10%)
MSFT   236.55 (+1.79%)
FB   262.03 (+1.71%)
GOOGL   2,057.66 (+1.77%)
TSLA   709.64 (+5.05%)
AMZN   3,126.00 (+1.07%)
NVDA   546.34 (-0.41%)
BABA   240.66 (+1.22%)
CGC   34.79 (+6.23%)
GE   13.19 (+5.18%)
MU   93.96 (+2.65%)
NIO   49.69 (+8.54%)
AMD   85.75 (+1.47%)
T   28.19 (+1.08%)
F   11.98 (+2.39%)
ACB   11.21 (+6.56%)
DIS   194.37 (+2.82%)
BA   223.06 (+5.21%)
NFLX   548.12 (+1.72%)
BAC   35.87 (+3.34%)
Log in
NASDAQ:TLRY

Tilray Stock Forecast, Price & News

$25.95
+1.59 (+6.53 %)
(As of 03/1/2021 01:33 PM ET)
Add
Compare
Today's Range
$24.80
Now: $25.95
$26.61
50-Day Range
$11.31
MA: $23.29
$63.91
52-Week Range
$2.43
Now: $25.95
$67.00
Volume392,570 shs
Average Volume51.13 million shs
Market Capitalization$4.46 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.12
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Tilray logo

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLRY
CUSIPN/A
CIKN/A
Phone206-432-9325
Employees1,646
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$166.98 million
Book Value$2.78 per share

Profitability

Net Income$-321,170,000.00
Net Margins-242.60%

Miscellaneous

Market Cap$4.46 billion
Next Earnings Date5/10/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.97 out of 5 stars

Medical Sector

1036th out of 1,965 stocks

Medicinals & Botanicals Industry

7th out of 33 stocks

Analyst Opinion: 1.9Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$25.95
+1.59 (+6.53 %)
(As of 03/1/2021 01:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLRY News and Ratings via Email

Sign-up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tilray (NASDAQ:TLRY) Frequently Asked Questions

Is Tilray a buy right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last twelve months. There are currently 2 sell ratings and 12 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Tilray stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View analyst ratings for Tilray
or view top-rated stocks.

What stocks does MarketBeat like better than Tilray?

Wall Street analysts have given Tilray a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tilray wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Tilray?

Tilray saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 34,370,000 shares, an increase of 23.9% from the December 31st total of 27,730,000 shares. Based on an average daily trading volume, of 27,140,000 shares, the days-to-cover ratio is currently 1.3 days.
View Tilray's Short Interest
.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Monday, May 10th 2021.
View our earnings forecast for Tilray
.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) announced its quarterly earnings data on Monday, November, 9th. The company reported ($0.02) EPS for the quarter, topping the Zacks' consensus estimate of ($0.21) by $0.19. The firm earned $51.41 million during the quarter, compared to analysts' expectations of $54.91 million. Tilray had a negative net margin of 242.60% and a negative trailing twelve-month return on equity of 92.70%. Tilray's revenue was up .6% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.36) earnings per share.
View Tilray's earnings history
.

How has Tilray's stock been impacted by Coronavirus (COVID-19)?

Tilray's stock was trading at $7.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TLRY stock has increased by 264.6% and is now trading at $25.85.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TLRY?

14 equities research analysts have issued 1-year price targets for Tilray's stock. Their forecasts range from $4.75 to $32.00. On average, they expect Tilray's stock price to reach $18.08 in the next year. This suggests that the stock has a possible downside of 30.1%.
View analysts' price targets for Tilray
or view top-rated stocks among Wall Street analysts.

Who are Tilray's key executives?

Tilray's management team includes the following people:
  • Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
  • Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
  • Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
  • Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board

What is Brendan Kennedy's approval rating as Tilray's CEO?

32 employees have rated Tilray CEO Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among Tilray's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tilray's key competitors?

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Square (SQ).

When did Tilray IPO?

(TLRY) raised $135 million in an IPO on Thursday, July 19th 2018. The company issued 9,000,000 shares at a price of $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by a number of institutional and retail investors. Top institutional shareholders include ETF Managers Group LLC (5.22%), Founders Fund V Management LLC (0.45%), Magnetar Financial LLC (0.31%), Graham Capital Management L.P. (0.14%), Princeton Global Asset Management LLC (0.12%) and Raymond James Financial Services Advisors Inc. (0.11%). Company insiders that own Tilray stock include Brendan Kennedy, Christine StClare, Edward Wood Pastorius Jr, Mark Castaneda, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends for Tilray
.

Which institutional investors are selling Tilray stock?

TLRY stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Engineers Gate Manager LP, and Stelac Advisory Services LLC. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, Christine StClare, Maryscott Greenwood, and Michael Auerbach.
View insider buying and selling activity for Tilray
or view top insider-selling stocks.

Which institutional investors are buying Tilray stock?

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Founders Fund V Management LLC, ETF Managers Group LLC, Magnetar Financial LLC, Graham Capital Management L.P., Raymond James Financial Services Advisors Inc., Seven Eight Capital LP, Nuveen Asset Management LLC, and Credit Suisse AG.
View insider buying and selling activity for Tilray
or or view top insider-buying stocks.

How do I buy shares of Tilray?

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $25.85.

How much money does Tilray make?

Tilray has a market capitalization of $4.44 billion and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis.

How many employees does Tilray have?

Tilray employs 1,646 workers across the globe.

What is Tilray's official website?

The official website for Tilray is www.tilray.com.

Where are Tilray's headquarters?

Tilray is headquartered at 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.